FDA panel recommends pulling Makena, citing ineffectiveness of controversial preterm birth dru - 1br
- last year
The FDA advisory panel, made up of gynecologists, obstetricians and other fetal medicine experts, voted 14-1 to withdraw Makena from the market.
VIEW MORE : https://bit.ly/1breakingnews
VIEW MORE : https://bit.ly/1breakingnews